Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Travis

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|August 1, 2016
Non-invasive assessment of portal hypertension using quantitative magnetic resonance imagingNaaventhan Palaniyappan, Eleanor Cox, Christopher Bradley, et al.
Journal of Crohn'S & Colitis|June 4, 2019
Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell TransplantationChrissy Bolton, Nicola Burch, James Morgan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2024
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled TrialVipul Jairath, Brian G Feagan, Mark S Silverberg, et al.
Journal of Crohn'S & Colitis|August 5, 2016
Evolving Concepts in Phases I and II Drug Development for Crohn's DiseaseVipul Jairath, Barrett G Levesque, Niels Vande Casteele, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Journal of Crohn'S & Colitis|March 23, 2018
Corrigendum: Evolving Concepts in Phases I and II Drug Development for Crohn's DiseaseVipul Jairath, Barrett G Levesque, Niels Vande Casteele, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Journal of Crohn'S & Colitis|December 22, 2010
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit toolAndrea Cassinotti, Satish Keshav, Sandro Ardizzone, et al.
Crohn'S & Colitis 360|May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences SurveyRemo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Expert Review of Gastroenterology & Hepatology|March 21, 2024
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trialsRish K Pai, Geert D'Haens, Taku Kobayashi, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|August 1, 2016
Non-invasive assessment of portal hypertension using quantitative magnetic resonance imagingNaaventhan Palaniyappan, Eleanor Cox, Christopher Bradley, et al.
Journal of Crohn'S & Colitis|June 4, 2019
Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell TransplantationChrissy Bolton, Nicola Burch, James Morgan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2024
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled TrialVipul Jairath, Brian G Feagan, Mark S Silverberg, et al.
Journal of Crohn'S & Colitis|August 5, 2016
Evolving Concepts in Phases I and II Drug Development for Crohn's DiseaseVipul Jairath, Barrett G Levesque, Niels Vande Casteele, et al.
Gut|October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitisWilliam J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Journal of Crohn'S & Colitis|March 23, 2018
Corrigendum: Evolving Concepts in Phases I and II Drug Development for Crohn's DiseaseVipul Jairath, Barrett G Levesque, Niels Vande Casteele, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Journal of Crohn'S & Colitis|December 22, 2010
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit toolAndrea Cassinotti, Satish Keshav, Sandro Ardizzone, et al.
Crohn'S & Colitis 360|May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences SurveyRemo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Expert Review of Gastroenterology & Hepatology|March 21, 2024
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trialsRish K Pai, Geert D'Haens, Taku Kobayashi, et al.
Pageof 17